CASTLE BIOSCIENCES, INC. Deferred Tax Assets, Operating Loss Carryforwards
CASTLE BIOSCIENCES, INC. (CSTL) had Deferred Tax Assets, Operating Loss Carryforwards of $33.83 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-02-26
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $33.83M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $31.78M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $47.16M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $49.25M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $33.83M 10-K · filed 2026-02-26 |
| 2024-12-31 | $31.78M 10-K · filed 2026-02-26 |
| 2023-12-31 | $47.16M 10-K · filed 2025-02-27 |
| 2022-12-31 | $49.25M 10-K · filed 2024-02-28 |
| 2021-12-31 | $24.32M 10-K · filed 2023-02-28 |
| 2020-12-31 | $13.72M 10-K · filed 2022-02-28 |
| 2019-12-31 | $14.08M 10-K · filed 2021-03-11 |
| 2018-12-31 | $16.18M 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |